ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN

Abstract Osteoporosis (OP) is a metabolic bone disease characterized by progressive decline of bone mass and bone quality, leading to bone fragility and an increased risk of fracture. The osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is crucial to maintain the balance of osteobla...

Full description

Saved in:
Bibliographic Details
Main Authors: Hairong Su, Linyuan Liang, Junling Wang, Xiaolu Yuan, Binxiu Zhao
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-024-05232-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846165070287994880
author Hairong Su
Linyuan Liang
Junling Wang
Xiaolu Yuan
Binxiu Zhao
author_facet Hairong Su
Linyuan Liang
Junling Wang
Xiaolu Yuan
Binxiu Zhao
author_sort Hairong Su
collection DOAJ
description Abstract Osteoporosis (OP) is a metabolic bone disease characterized by progressive decline of bone mass and bone quality, leading to bone fragility and an increased risk of fracture. The osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is crucial to maintain the balance of osteoblast and osteoclast. Bioinformatics prediction indicates that ZFP36 ring finger protein (ZFP36), an RNA-binding protein, is a potential target of OP. Herein, we sought to probe the regulatory role and mechanisms of ZFP36 in the progression of OP. Overexpression of ZFP36 enhanced osteoblast viability, differentiation and mineralization of human BMSCs (hBMSCs). RNA immunoprecipitation qPCR (RIP-qPCR) assays demonstrated that ZFP36 could inhibit the translation of JUN, which was also verified with dual luciferase reporter gene assay. Furthermore, administration with T-5224, a transcription factor c-Fos/activator protein (AP)-1 inhibitor, which specifically inhibits the DNA binding activity of c-Fos/JUN, abolished the effect of ZFP36 knockdown on the behaviors of hBMSCs, suggesting that ZFP36 might promotes osteogenic differentiation through regulating JUN. These findings provide insights into the progression and a potential therapeutic target of OP.
format Article
id doaj-art-c10c09c7d2fa4f0c81213226bdc999c2
institution Kabale University
issn 1749-799X
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-c10c09c7d2fa4f0c81213226bdc999c22024-11-17T12:38:16ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2024-11-011911910.1186/s13018-024-05232-7ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUNHairong Su0Linyuan Liang1Junling Wang2Xiaolu Yuan3Binxiu Zhao4Maoming People’s HospitalMaoming People’s HospitalThe Second Affiliated Hospital of Guangzhou, University of Chinese MedicineMaoming People’s HospitalMaoming People’s HospitalAbstract Osteoporosis (OP) is a metabolic bone disease characterized by progressive decline of bone mass and bone quality, leading to bone fragility and an increased risk of fracture. The osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is crucial to maintain the balance of osteoblast and osteoclast. Bioinformatics prediction indicates that ZFP36 ring finger protein (ZFP36), an RNA-binding protein, is a potential target of OP. Herein, we sought to probe the regulatory role and mechanisms of ZFP36 in the progression of OP. Overexpression of ZFP36 enhanced osteoblast viability, differentiation and mineralization of human BMSCs (hBMSCs). RNA immunoprecipitation qPCR (RIP-qPCR) assays demonstrated that ZFP36 could inhibit the translation of JUN, which was also verified with dual luciferase reporter gene assay. Furthermore, administration with T-5224, a transcription factor c-Fos/activator protein (AP)-1 inhibitor, which specifically inhibits the DNA binding activity of c-Fos/JUN, abolished the effect of ZFP36 knockdown on the behaviors of hBMSCs, suggesting that ZFP36 might promotes osteogenic differentiation through regulating JUN. These findings provide insights into the progression and a potential therapeutic target of OP.https://doi.org/10.1186/s13018-024-05232-7OsteoporosisZFP36 ring finger proteinJUNOsteogenic differentiation
spellingShingle Hairong Su
Linyuan Liang
Junling Wang
Xiaolu Yuan
Binxiu Zhao
ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
Journal of Orthopaedic Surgery and Research
Osteoporosis
ZFP36 ring finger protein
JUN
Osteogenic differentiation
title ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
title_full ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
title_fullStr ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
title_full_unstemmed ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
title_short ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN
title_sort zfp36 an rna binding protein promotes hbmscs osteogenic differentiation via binding with jun
topic Osteoporosis
ZFP36 ring finger protein
JUN
Osteogenic differentiation
url https://doi.org/10.1186/s13018-024-05232-7
work_keys_str_mv AT hairongsu zfp36anrnabindingproteinpromoteshbmscsosteogenicdifferentiationviabindingwithjun
AT linyuanliang zfp36anrnabindingproteinpromoteshbmscsosteogenicdifferentiationviabindingwithjun
AT junlingwang zfp36anrnabindingproteinpromoteshbmscsosteogenicdifferentiationviabindingwithjun
AT xiaoluyuan zfp36anrnabindingproteinpromoteshbmscsosteogenicdifferentiationviabindingwithjun
AT binxiuzhao zfp36anrnabindingproteinpromoteshbmscsosteogenicdifferentiationviabindingwithjun